On this page:Overview Publications Researchers Institutions Open access

ScholarIQanswers from OpenAlex

European Organisation for Research and Treatment of Cancer

InstitutionResearch output, impact & collaborations

European Organisation for Research and Treatment of Cancer is a institution indexed in ScholarIQ from OpenAlex.

What is known about European Organisation for Research and Treatment of Cancer?

ScholarIQrecord summary

European Organisation for Research and Treatment of Cancer is a research organisation in Brussels, BE. OpenAlex records 3,581 works and 766,352 citations for it. 519 researchers list it as their most recent affiliation.

How many works does European Organisation for Research and Treatment of Cancer have?

ScholarIQindexed works

European Organisation for Research and Treatment of Cancer has 3,581 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for European Organisation for Research and Treatment of Cancer →

How many citations does European Organisation for Research and Treatment of Cancer have?

ScholarIQcitation count

European Organisation for Research and Treatment of Cancer has 766,352 citations in the OpenAlex counts ScholarIQ stores.

See the listed works for European Organisation for Research and Treatment of Cancer →

How many researchers are at European Organisation for Research and Treatment of Cancer?

ScholarIQresearcher count

European Organisation for Research and Treatment of Cancer has 519 researchers in the ScholarIQ index.

See the researchers listed on this page →

What is the average h-index at European Organisation for Research and Treatment of Cancer?

ScholarIQavg h-index

European Organisation for Research and Treatment of Cancer has an average h-index of 50.8 in OpenAlex.

Open the OpenAlex record →

What is the ROR of European Organisation for Research and Treatment of Cancer?

ScholarIQror

The ROR for European Organisation for Research and Treatment of Cancer is on the source record.

Open the ROR →

What is the OpenAlex record for European Organisation for Research and Treatment of Cancer?

ScholarIQopenalex

The OpenAlex for European Organisation for Research and Treatment of Cancer is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind European Organisation for Research and Treatment of Cancer?

ScholarIQtop researchers by citations

Denis Lacombe · Health Systems, Economic Evaluations, Quality of Life

163 works67,334 citations

Anouk Allgeier · Glioma Diagnosis and Treatment

46 works35,071 citations

Stefan Suciu · Acute Myeloid Leukemia Research

422 works23,097 citations

N. Duez · Gastric Cancer Management and Outcomes

69 works21,529 citations

Andrew Bottomley · Cancer survivorship and care

346 works20,490 citations

What are the most-cited papers on European Organisation for Research and Treatment of Cancer?

ScholarIQmost cited works

Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma

Alexander M.M. Eggermont, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Haydon, Mikhail Lichinitser, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger H.T. Koornstra, Leonel F. Hernandez‐Aya, Michele Maio, Alfonsus Johannes Maria van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Paul Lorigan, Nageatte Ibrahim, Sandrine Marréaud, Alexander C. J. van Akkooi, Stefan Suciu, Caroline Robert

New England Journal of Medicine. 20181,870 CitationsOPEN ACCESS

The development of the EORTC QLQ-C15-PAL: A shortened questionnaire for cancer patients in palliative care

Mogens Grøenvold, Morten Aagaard Petersen, Neil K. Aaronson, Juan Ignacio Arrarás, Jane Blazeby, Andrew Bottomley, Peter Fayers, Alexander de Graeff, Eva Hammerlid, Stein Kaasa, Mirjam A. G. Sprangers, Jakob Bue Bjørner

European Journal of Cancer. 2005696 Citations

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial

Sylvie Bonvalot, Alessandro Gronchi, C. Le Péchoux, Carol J. Swallow, D. Strauß, Pierre Méeus, Frits van Coevorden, Stephan Stoldt, Eberhard Stoeckle, Piotr Rutkowski, Marco Rastrelli, Chandrajit P. Raut, Daphne Hompes, Antonino De Paoli, Claudia Sangalli, Charles Honoré, Peter Chung, Aisha Miah, Jean‐Yves Blay, Marco Fiore, Jean‐Jacques Stelmes, Angelo Paolo Dei Tos, Elizabeth H. Baldini, Saskia Litière, Sandrine Marréaud, Hans Gelderblom, Rick L. Haas

The Lancet Oncology. 2020492 CitationsOPEN ACCESS

The value of preoperative radiotherapy in esophageal cancer: Results of a study of the E.O.R.T.C.

M Gignoux, A Roussel, B Paillot, M Gillet, P. Schlag, Jean‐Pierre Favre, Otilia Dalesio, Marc Buyse, N. Duez

World Journal of Surgery. 1987295 Citations

Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy

Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken, for the EORTC Head and Neck Cancer Cooperative Group and the EORTC Radiation Oncology Group

JNCI Journal of the National Cancer Institute. 2009282 CitationsOPEN ACCESS

How much of the research on European Organisation for Research and Treatment of Cancer is open access?

ScholarIQopen access share

71%OPEN ACCESS

Gold

Green

Hybrid

29%

Bronze

43%

Closed

29%